JENNIFER GEORGE-MCKNIGHT: Open Payments
NPI 1558529966 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $325 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Alkermes, Inc. | 1 | $17 |
Products named: REXULTI, TRINTELLIX, Auvelity, Jornay PM, INGREZZA, ARISTADA.
Industry payments across AR — which companies pay providers there.
